Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia

Mise à jour : Il y a 4 ans
Référence : NCT00487253

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this randomized, open label clinical trial is to determine if oral miltefosine is a safe and effective alternative, compared with parenteral meglumine antimoniate for the treatment of pediatric Cutaneous caused by L. Viannia species in Colombia.


Critère d'inclusion

  • Cutaneous Leishmaniasis

Liens